KVD900 as a Single Dose, Rapid, Oral Plasma Kallikrein...

Journal of Allergy and Clinical Immunology 2019 / 02 Vol. 143; Iss. 2

KVD900 as a Single Dose, Rapid, Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema Attacks: Pharmacokinetic and Pharmacodynamic results from a Phase 1 Single Ascending Dose Study

Hampton, Sally L., De Donatis, Gian Marco, Murugesan, Nivetha I., Rushbrooke, Louise J., Li, Lily, Duckworth, Edward, Smith, Michael D., Morten, Rachel M., Maetzel, Andreas, Yea, Christopher M., Feene
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
143
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2018.12.118
Date:
February, 2019
File:
PDF, 81 KB
english, 2019
Conversion to is in progress
Conversion to is failed